IMCR Stock Analysis: Buy, Sell, or Hold?
IMCR - Immunocore Holdings plc American Depositary Shares
$28.76
-0.19 (-0.66%)
▼
5d:
-6.07%
30d:
-9.1%
90d:
-9.53%
HOLD
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When IMCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IMCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IMCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IMCR is currently trading at $28.76, which is considered slightly low relative to its 30-day fair value range of $28.66 to $31.42.
Technical Outlook: Technically, IMCR is in a strong downtrend. Immediate support is located at $27.55, while resistance sits at $31.48.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $63.80 (+121.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IMCR is in a strong downtrend. Immediate support is located at $27.55, while resistance sits at $31.48.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $63.80 (+121.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$28.66 -
$31.42
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 121.8% below Wall St target ($63.80)
- CAUTION: Recommendation downgraded due to -6.1% 5-day decline
Trading Range Analysis
30-Day Trading Range
$28.66 -
$31.42
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$27.56
Resistance Level
$31.48
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-80.27
Wall Street Target
$63.80
(+121.8%)
Revenue Growth (YoY)
24.3%
Earnings Growth (YoY)
822.0%
Profit Margin
-8.9%
Share & Embed Analysis
Last updated: May 15, 2026 3:42 AM ET
Data refreshes hourly during market hours. Next update: 4:42 AM
Data refreshes hourly during market hours. Next update: 4:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Bahija Jallal
SELL
11474 shares
2026-02-18
David M Berman
SELL
5965 shares
2026-02-18
John Goll
SELL
698 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 60 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 59 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 57 HOLD |
